Hcw Biologics Stock Market Value
| HCWB Stock | USD 0.27 0.01 5.04% |
| Symbol | HCW |
HCW Biologics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HCW Biologics. If investors know HCW will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HCW Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of HCW Biologics is measured differently than its book value, which is the value of HCW that is recorded on the company's balance sheet. Investors also form their own opinion of HCW Biologics' value that differs from its market value or its book value, called intrinsic value, which is HCW Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HCW Biologics' market value can be influenced by many factors that don't directly affect HCW Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HCW Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if HCW Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HCW Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
HCW Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HCW Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HCW Biologics.
| 11/01/2024 |
| 01/30/2025 |
If you would invest 0.00 in HCW Biologics on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding HCW Biologics or generate 0.0% return on investment in HCW Biologics over 90 days. HCW Biologics is related to or competes with Anebulo Pharmaceuticals, Rezolute, Molecular Partners, MediciNova, Champions Oncology, Pmv Pharmaceuticals, and Pharvaris. HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunothe... More
HCW Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HCW Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HCW Biologics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.2 | |||
| Information Ratio | 0.0479 | |||
| Maximum Drawdown | 352.85 | |||
| Value At Risk | (13.64) | |||
| Potential Upside | 8.51 |
HCW Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HCW Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HCW Biologics' standard deviation. In reality, there are many statistical measures that can use HCW Biologics historical prices to predict the future HCW Biologics' volatility.| Risk Adjusted Performance | 0.0517 | |||
| Jensen Alpha | 2.26 | |||
| Total Risk Alpha | (1.64) | |||
| Sortino Ratio | 0.215 | |||
| Treynor Ratio | (0.74) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HCW Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
HCW Biologics Backtested Returns
HCW Biologics is out of control given 3 months investment horizon. HCW Biologics holds Efficiency (Sharpe) Ratio of 0.0602, which attests that the company had a 0.0602 % return per unit of volatility over the last 3 months. We are able to interpolate and break down twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.61% are justified by taking the suggested risk. Use HCW Biologics market risk adjusted performance of (0.73), and Semi Deviation of 7.44 to evaluate company specific risk that cannot be diversified away. HCW Biologics holds a performance score of 4 on a scale of zero to a hundred. The firm retains a Market Volatility (i.e., Beta) of -2.78, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning HCW Biologics are expected to decrease by larger amounts. On the other hand, during market turmoil, HCW Biologics is expected to outperform it. Use HCW Biologics potential upside and the relationship between the skewness and period momentum indicator , to analyze future returns on HCW Biologics.
Auto-correlation | 0.35 |
Below average predictability
HCW Biologics has below average predictability. Overlapping area represents the amount of predictability between HCW Biologics time series from 1st of November 2024 to 16th of December 2024 and 16th of December 2024 to 30th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HCW Biologics price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current HCW Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
HCW Biologics lagged returns against current returns
Autocorrelation, which is HCW Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting HCW Biologics' stock expected returns. We can calculate the autocorrelation of HCW Biologics returns to help us make a trade decision. For example, suppose you find that HCW Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
HCW Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If HCW Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if HCW Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in HCW Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
HCW Biologics Lagged Returns
When evaluating HCW Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of HCW Biologics stock have on its future price. HCW Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, HCW Biologics autocorrelation shows the relationship between HCW Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in HCW Biologics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether HCW Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HCW Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hcw Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hcw Biologics Stock:Check out HCW Biologics Correlation, HCW Biologics Volatility and HCW Biologics Alpha and Beta module to complement your research on HCW Biologics. For information on how to trade HCW Stock refer to our How to Trade HCW Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
HCW Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.